Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 3
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2219AFP, GGT, ALT, ASTProteinMale Sprague-Dawley ratsDownregulated Potential Prognostic *HCC v/s Normal/treated with AEA; associated with progression p < 0.0001Serum28900384
2555KIAA0959 protein, thymosin beta 4 Y isoform(TB4Y)mRNA, Pig7 (PIG7) mRNA, Fas binding protein (hDaxx), putative lung tumor suppressor(DAL1) mRNA complete cds, novel chemokine family member with altered, mRNA for Src-like adapter protein, OSF-1, Hu lambda-17 lambda-like protein (IGLL2), helix-loop-helRNAsHumanDownregulated in HCC than non-tumor DiagnosticTumor v/s normal NATissue12136251
2580Dystrophin, Homolog to tubulin beta chain, Zinc finger protein 337, Friedreich ataxia region gene X123, Fibronectin (Alt. Splice 1), Zinc finger protein 9, Metallothionein IV, Poly(rC) binding protein 3, KIAA0426 gene product, Hypothetical protein FLJ13910, RAN binding protein 2 like 1, S100 calciumRNAsHumanDownregulated in L1 than L0 (with fisher ratio more than 9.74) Prognostic non-tumorous livers L1 (with HCV infection) v/s and L0 (without HCV infection) ; associated with invasion or metastsis P = 0.001Tissue15710396

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top